Author Archives: JAIDS

PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A…

Objective: To estimate preterm birth risk among infants of HIV-infected women in Lilongwe, Malawi, according to maternal antiretroviral therapy (ART) status and initiation time under Option B+.

Posted in Journal Watch | Comments closed

Differences in Risk Behavior and Demographic Factors Between Men Who Have Sex With Men With…

Introduction: High viremia combined with HIV-infection status unawareness and increased sexual risk behavior contributes to a disproportionate amount of new HIV infections.

Posted in Journal Watch | Comments closed

HIV and Hormonal Contraception: Bench and Bedside

No abstract available

Posted in Gender, HIV/AIDS, Infectious Disease, Journal Watch, Medications & Treatments, Research, Social | Tagged , | Comments closed

Prescription of Postexposure Prophylaxis for HIV-1 in the Emergency Room: Correct Transmission…

Background: Limited data are available about the accuracy of postexposure prophylaxis (PEP) prescription in the emergency rooms.

Posted in HIV/AIDS, Infectious Disease, Journal Watch | Tagged , | Comments closed

HIV-Related Sexual Risk Among Transgender Men Who Are Gay, Bisexual, or Have Sex With Men

Background: This study is among the first to examine factors associated with HIV-related sexual risk among transgender men and other transmasculine persons who are gay, bisexual, or have sex with men (T-GBMSM).

Posted in Gender, HIV/AIDS, Infectious Disease, Journal Watch, Men's Health, Social | Tagged , | Comments closed

Xpert HIV-1 Viral Load Assay and VERSANT HIV-1 RNA 1.5 Assay: A Performance Comparison

No abstract available

Posted in HIV/AIDS, Infectious Disease, Journal Watch | Tagged | Comments closed

Rural Health More Than Just “Big Data”

No abstract available

Posted in Journal Watch | Comments closed

Characterization of HCV NS3 Protease Variants in HCV/HIV-Coinfected Patients by Ultra-Deep…

Background: Treatment of HCV/HIV coinfection is now largely based on utilization of direct acting agents.

Posted in Journal Watch | Comments closed

Brief Report: Soluble CD163 in CMV-Infected and CMV-Uninfected Subjects on Virologically…

Aims: To contribute to the understanding of the role played by cytomegalovirus (CMV) in sustaining monocyte/macrophage-mediated immune activation in antiretroviral therapy treated HIV-infected subjects.

Posted in Journal Watch | Comments closed

Creation of a Long-Acting Nanoformulated 2′,3′-Dideoxy-3′-Thiacytidine

Background: Antiretroviral drug discovery and formulation design will facilitate viral clearance in infectious reservoirs.

Posted in Journal Watch | Comments closed

MZC Gel Inhibits SHIV-RT and HSV-2 in Macaque Vaginal Mucosa and SHIV-RT in Rectal Mucosa

Abstract: The Population Council’s microbicide gel MZC (also known as PC-1005) containing MIV-150 and zinc acetate dihydrate (ZA) in carrageenan (CG) has shown promise as a broad-spectrum microbicide against HIV, herpes simplex virus (HSV), and human papillomavirus.

Posted in Journal Watch | Comments closed

Brief Report: Flow Rate of Cerebrospinal Fluid Through a Spinal Needle Can Accurately Predict…

Background: Patients with HIV-associated cryptococcal meningitis (CM) commonly present with raised intracranial pressure (ICP).

Posted in Journal Watch | Comments closed

Relationship Between HIV Infection, Antiretroviral Therapy, Inflammatory Markers, and…

Background: Cerebrovascular risk is increased in people living with HIV infection compared with age-matched uninfected individuals.

Posted in Journal Watch | Comments closed

Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International…

Objectives: The International HIV Dementia Scale (IHDS) was developed to screen for HIV-associated dementia, but it has been used more generally for HIV-associated neurocognitive disorder (HAND).

Posted in Journal Watch | Comments closed